KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Sales (2016 - 2025)

Historic Return on Sales for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to 0.35%.

  • Vertex Pharmaceuticals' Return on Sales fell 300.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.05% for FY2024, which is 4200.0% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Return on Sales of 0.35% as of Q3 2025, which was down 300.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Return on Sales ranged from a high of 0.43% in Q3 2021 and a low of 1.36% during Q2 2024
  • Over the past 5 years, Vertex Pharmaceuticals' median Return on Sales value was 0.37% (recorded in 2023), while the average stood at 0.25%.
  • In the last 5 years, Vertex Pharmaceuticals' Return on Sales tumbled by -17300bps in 2024 and then soared by 17100bps in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Return on Sales stood at 0.37% in 2021, then dropped by -4bps to 0.36% in 2022, then rose by 8bps to 0.38% in 2023, then decreased by -19bps to 0.31% in 2024, then increased by 12bps to 0.35% in 2025.
  • Its Return on Sales stands at 0.35% for Q3 2025, versus 0.35% for Q2 2025 and 0.23% for Q1 2025.